Skip to Main Content
  • Yale Cancer Center
    Yale New Haven Hospital
    20 York Street, Ste North Pavilion 7
    New Haven, CT 06510

Iris Isufi, MD

Medical Oncology, Hematology & Oncology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Medical Oncology

Biography

Iris Isufi, MD, is a hematologist who specializes in treating patients with lymphoma, multiple lymphoma, and leukemia. Dr. Isufi provides care through treatments involving cellular therapy, which include CAR T-cell therapy and stem cell transplants. She is co-director of the CAR T-Cell Therapy Program for adults.

“Cell therapies like CAR T-cell therapy are promising for diseases that haven’t responded to multiple types of treatment,” Dr. Isufi says. “It’s a recent development, but one that students in medical school are already learning about, and that’s very exciting.”

The potential benefit of CAR T-cell therapy matters especially to Dr. Isufi, who grew up in Albania and sometimes accompanied her mother, a physician, on rounds at the hospital. “I saw challenges they [the doctors] were facing in trying to help people. Their determination inspired me when I was young to become a physician,” Dr. Isufi says.

As she visits her cancer patients today, Dr. Isufi spends time getting to know each one so that she can provide reassurance for each person’s unique situation. “I tell them we are in this together and that I’ll do my best to help them get through it all—beginning to end,” she says. Dr. Isufi continues to check in on patients who have been in remission for many years after receiving their treatment.

“My patients are very grateful, brave, and courageous, and this inspires me,” she says.

Dr. Isufi is an assistant professor of hematology at Yale School of Medicine, where she also runs clinical trials in patients with lymphoma. 

Titles

  • Associate Professor of Medicine (Hematology)
  • Co-Director Adult CAR T-Cell Therapy Program, Hematology
  • Co-Leader, Cellular Therapy Disease Aligned Research Team (DART), Yale Cancer Center
  • Co-Chair, Cellular Therapy (CT)-SAFE Committee, Yale Cancer Center

Education & Training

  • Fellowship
    Yale University School of Medicine (2011)
  • Residency
    Albert Einstein College of Medicine/Montefiore Medical Center (2007)
  • MD
    State University of New York at Stony Brook (2004)
  • BA
    The College of Saint Rose, Albany, NY, 2000, Biology (2000)

Languages Spoken

  • English
  • Italiano (Italian)
  • Español (Spanish)

Additional Information

Biography

Iris Isufi, MD, is a hematologist who specializes in treating patients with lymphoma, multiple lymphoma, and leukemia. Dr. Isufi provides care through treatments involving cellular therapy, which include CAR T-cell therapy and stem cell transplants. She is co-director of the CAR T-Cell Therapy Program for adults.

“Cell therapies like CAR T-cell therapy are promising for diseases that haven’t responded to multiple types of treatment,” Dr. Isufi says. “It’s a recent development, but one that students in medical school are already learning about, and that’s very exciting.”

The potential benefit of CAR T-cell therapy matters especially to Dr. Isufi, who grew up in Albania and sometimes accompanied her mother, a physician, on rounds at the hospital. “I saw challenges they [the doctors] were facing in trying to help people. Their determination inspired me when I was young to become a physician,” Dr. Isufi says.

As she visits her cancer patients today, Dr. Isufi spends time getting to know each one so that she can provide reassurance for each person’s unique situation. “I tell them we are in this together and that I’ll do my best to help them get through it all—beginning to end,” she says. Dr. Isufi continues to check in on patients who have been in remission for many years after receiving their treatment.

“My patients are very grateful, brave, and courageous, and this inspires me,” she says.

Dr. Isufi is an assistant professor of hematology at Yale School of Medicine, where she also runs clinical trials in patients with lymphoma. 

Titles

  • Associate Professor of Medicine (Hematology)
  • Co-Director Adult CAR T-Cell Therapy Program, Hematology
  • Co-Leader, Cellular Therapy Disease Aligned Research Team (DART), Yale Cancer Center
  • Co-Chair, Cellular Therapy (CT)-SAFE Committee, Yale Cancer Center

Education & Training

  • Fellowship
    Yale University School of Medicine (2011)
  • Residency
    Albert Einstein College of Medicine/Montefiore Medical Center (2007)
  • MD
    State University of New York at Stony Brook (2004)
  • BA
    The College of Saint Rose, Albany, NY, 2000, Biology (2000)

Languages Spoken

  • English
  • Italiano (Italian)
  • Español (Spanish)

Additional Information

  • Yale Cancer Center
    Yale New Haven Hospital
    20 York Street, Ste North Pavilion 7
    New Haven, CT 06510